We at Gohar Group, have dedicated set up for serving our clients (both national & international) under our company Techind Engineers & Consultants-Impex. We provide various professional management services such as: Joint Business promotion for our foreign partner & Principals with Representation & Distribution of machinery, equipment & technology, in our territory. Our PAN India reach and reps. helps or partners for faster success to establish their product and services, in mutual interest & benefit.
India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK. Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The domestic pharmaceutical industry includes a network of 3,000 drug companies and ~10,500 manufacturing units.
India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers with a potential to steer the industry ahead to greater heights. Presently, over 80% of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms.
Healthcare has become one of India’s largest sectors, both in terms of revenue and employment. Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance and medical equipment. The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services and increasing expenditure by public as well private players.
Indian healthcare delivery system is categorised into two major components public and private. The Government, i.e., public healthcare system, comprises limited secondary and tertiary care institutions in key cities and focuses on providing basic healthcare facilities in the form of primary healthcare centres (PHCs) in rural areas. The private sector provides majority of secondary, tertiary, and quaternary care institutions with major concentration in metros and tier I and tier II cities.
India’s competitive advantage lies in its large pool of well-trained medical professionals. India is also cost competitive compared to its peers in Asia and Western countries. The cost of surgery in India is about one-tenth of that in the US or Western Europe.
As of November 19, 2021, >115 crore COVID-19 vaccine doses have been administered across the country. We also deal into various types of Medical and diagnostic machines/ equipment for Hospital and R&D institutes and Hospitals both in Government & Private sector. We have commissioned over 100 projects in various industry sectors and Machinery, equipment, and technology we handled mainly in pharma sector: